Forte Biosciences (FBRX) Shares Outstanding (2016 - 2026)

Forte Biosciences (FBRX) has 7 years of Shares Outstanding (Entity) data on file, last reported at $2.9 million in Q4 2024.

• On a quarterly basis, Shares Outstanding (Entity) rose 100.63% year-over-year to $2.9 million in Q4 2024; TTM through Dec 2024 was $2.9 million, a 100.63% increase from a year earlier, with the FY2024 full-year figure at $2.9 million, up 100.63% from the prior year.
• Shares Outstanding (Entity) for Q4 2024 stood at $2.9 million, up from $1.8 million in the prior quarter.
• Over the last five years, Shares Outstanding (Entity) for FBRX reached as high as $530.1 million in Q1 2021 and fell as low as $63776.0 in Q1 2020.
• Historically, Shares Outstanding (Entity) has averaged $57.1 million across 5 years, with a median of $841165.5 in 2023.
• Across the five-year window, Shares Outstanding (Entity) surged 831116.82% in 2021 and plunged 99.89% in 2022, its largest moves.
• Year by year, Shares Outstanding (Entity) stood at $294357.0 in 2020, then surged by 100.5% to $590178.0 in 2021, then rose by 17.82% to $695341.0 in 2022, then soared by 109.02% to $1.5 million in 2023, then jumped by 100.63% to $2.9 million in 2024.
• Per Business Quant data, the three most recent Shares Outstanding (Entity) figures were $2.9 million in Q4 2024, $1.8 million in Q3 2024, and $1.8 million in Q2 2024.